Home » Stocks » BTCY

Biotricity Inc. (BTCY)

Stock Price: $2.55 USD 0.26 (11.35%)
Updated Feb 26, 2021 3:58 PM EST - Market closed
Market Cap 98.12M
Revenue (ttm) 1.96M
Net Income (ttm) -15.50M
Shares Out 37.26M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $2.55
Previous Close $2.29
Change ($) 0.26
Change (%) 11.35%
Day's Open 2.63
Day's Range 2.10 - 2.64
Day's Volume 327,644
52-Week Range 0.67 - 2.64

News

Hide News
GlobeNewsWire - 2 weeks ago

REDWOOD CITY, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) --  Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss ...

GlobeNewsWire - 1 month ago

REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a s...

About BTCY

Biotricity, medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG reading... [Read more...]

Industry
Medical Devices
CEO
Dr. Waqaas Al-Siddiq Ph.D.
Employees
24
Stock Exchange
OTCMKTS
Ticker Symbol
BTCY
Full Company Profile

Financial Performance

In 2019, Biotricity's revenue was $1.42 million, an increase of 256.03% compared to the previous year's $398,200. Losses were -$11.07 million, 28.8% more than in 2018.

Financial Statements